| AR | androgen receptor |
| AR-V7 | an AR splice variant |
| ADT | androgen deprivation therapy |
| ARE | androgen response element |
| Bic | bicalutamide |
| CAF | cancer-associated fibroblasts |
| CRPC | castration-resistant prostate cancer |
| CTC | circulating tumor cells |
| CSC | cancer stem cell |
| DRPC | drug resistance Pca |
| DHT | dihydrotestosterone |
| EGFR | epidermal growth factor receptor |
| Enz | enzalutamide |
| EMT | epithelial-mesenchymal transition |
| GR | glucocorticoid receptor |
| LCoR | ligand-dependent co-repressor |
| mCRPC | metastatic CRPC |
| NLS | nuclear localization signal |
| NEPC | neuroendocrine prostate cancer |
| LBD | ligand-binding domain |
| NTD | amino-terminal domain |
| ODM | darolutamide |
| Pca | prostate cancer |
| PSA | prostate specific antigen |
| SFK | Src family of kinases |